この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2003/6/181 分で読めます
Safety Reporting Requirements for Human Drug and Biological Products; Extension of Comment Period
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is extending to October 14, 2003, the comment period for a proposed rule published in the Federal Register of March 14, 2003 (68 FR 12406). The proposed rule would amend the agency's pre- and postmarketing safety reporting regulations for human drug and biological products. The agency is taking this action in response to a request for more time to submit comments to FDA.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →